BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 17461909)

  • 41. MRI in patients with axillary metastases of occult breast carcinoma.
    Tilanus-Linthorst MM; Obdeijn AI; Bontenbal M; Oudkerk M
    Breast Cancer Res Treat; 1997 Jun; 44(2):179-82. PubMed ID: 9232276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Imaging in clinical practice. Infiltrating lobular carcinoma].
    Salem A; Mehiri S; Mnif N
    Tunis Med; 2007 Jun; 85(6):524-8. PubMed ID: 17644910
    [No Abstract]   [Full Text] [Related]  

  • 43. Invasive lobular carcinoma in a hypoplastic breast.
    Bassarova AV; Sedloev T; Christova SL; Trifonov DY; Nesland JM
    Ultrastruct Pathol; 2002; 26(6):411-4. PubMed ID: 12537766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Infiltrating lobular breast cancer: histological and immunohistochemical characteristics].
    Vishnevskaia IaV; Ermilova VD; Savelov NA; Nechushkin MI; Trigolosov AV; Petrovskiĭ AV; Chemeris GIu; Zakharova TI
    Arkh Patol; 2005; 67(4):17-21. PubMed ID: 16209292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Magnetic resonance in a case of lobular adenocarcinoma of the breast].
    Dalpiaz G; Zingarelli A; Anania G; Bazzocchi M
    Radiol Med; 1996 Apr; 91(4):475-7. PubMed ID: 8643864
    [No Abstract]   [Full Text] [Related]  

  • 46. Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?
    Zakaria S; Pantvaidya G; Reynolds CA; Grant CS; Sterioff S; Donohue JH; Farley DR; Hoskin TL; Degnim AC
    Surgery; 2008 May; 143(5):641-7. PubMed ID: 18436012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diagnostic difficulties in infiltrating lobular breast cancer: value of ultrasonography. 33 cases].
    Escolano E; Tournegros JM; Le Marc'Hadour F; Bernard P
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(8):781-8. PubMed ID: 9509318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer.
    Wasif N; Garreau J; Terando A; Kirsch D; Mund DF; Giuliano AE
    Am Surg; 2009 Oct; 75(10):970-5. PubMed ID: 19886147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Value of immunohistochemical detection of lymph node micrometastases in lobular carcinoma of the breast].
    Khattech R; Khattech A; Ben Othman M; Ben Romdhane K; Contesso G
    Tunis Med; 1995 Dec; 73(12):523-6. PubMed ID: 9506131
    [No Abstract]   [Full Text] [Related]  

  • 50. Occult breast carcinoma: a report of four cases and review of literature.
    Misra AK; Mishra A; Agrawal G; Agarwal A; Mishra SK
    Indian J Cancer; 2001 Mar; 38(1):49-54. PubMed ID: 14758886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bilateral synchronous breast carcinomas followed by a metastasis to the gallbladder: a case report.
    Zagouri F; Sergentanis TN; Koulocheri D; Nonni A; Bousiotou A; Domeyer P; Michalopoulos NV; Dardamanis D; Konstadoulakis MM; Zografos GC
    World J Surg Oncol; 2007 Sep; 5():101. PubMed ID: 17848197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Consensus Meeting of Course Directors in Breast Imaging, 9 May 2009, in Frankfurt am Main - Topic: Masses].
    Müller-Schimpfle MP; Heindel W; Kettritz U; Schulz-Wendtland R; Bick U
    Rofo; 2010 Aug; 182(8):671-5. PubMed ID: 20544579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of breast MRI in a patient with genetic risk.
    Cortesi L; Canossi B; De Santis M; Panizza P; Rossi G; Turchetti D; Del Maschio A; Ferrari S; Romagnoli R; Federico M; Silingardi V
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):131-6. PubMed ID: 12585667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast magnetic resonance imaging for preoperative locoregional staging.
    Hollingsworth AB; Stough RG; O'Dell CA; Brekke CE
    Am J Surg; 2008 Sep; 196(3):389-97. PubMed ID: 18436185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expectant management concerning the breast in 5 patients with occult breast carcinoma].
    van de Weijer GH; van Ooijen B; Hesp WL; Blom WF
    Ned Tijdschr Geneeskd; 1995 Aug; 139(32):1648-50. PubMed ID: 7566220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Who should have breast magnetic resonance imaging evaluation?
    Orel S
    J Clin Oncol; 2008 Feb; 26(5):703-11. PubMed ID: 18258977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast cancer metastatic to the vulva.
    Sheen-Chen SM; Eng HL; Huang CC
    Gynecol Oncol; 2004 Sep; 94(3):858-60. PubMed ID: 15350390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
    Alkuwari E; Auger M
    Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing.
    Erdahl LM; Boughey JC; Hoskin TL; Degnim AC; Hieken TJ
    Ann Surg Oncol; 2016 Jan; 23(1):72-7. PubMed ID: 26065870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.